The forecasted data for Parkinson's disease mortality in Canada shows an upward trend between 2024 and 2028. The figures, in deaths per hundred thousand males, indicate an increase from 12.0 in 2024 to 13.0 in 2028, marking a steady year-on-year growth. If we assume the 2023 rate was similar to 2024’s, this signifies a noticeable increment. Over the five-year projection, the Compound Annual Growth Rate (CAGR) reflects the consistent rise in male Parkinson’s-related mortality rates.
Future trends to watch for include advancements in medical treatments and healthcare policies that could mitigate this rise. Additionally, demographic shifts such as an aging population could influence these figures. Continued research and medical innovation are crucial in addressing Parkinson's mortality trends.
